U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
183091183091The Effects of a Supervised Exercise Program on Self Efficacy of People Living With HIV/AIDS.CompletedNo Results AvailableHIV InfectionsBehavioral: supervised exercisehttps://ClinicalTrials.gov/show/NCT00157170
183092183092Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A PatientsCompletedHas ResultsHemophilia ABiological: Recombinant Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)https://ClinicalTrials.gov/show/NCT00157157
183093183093Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005CompletedNo Results AvailableRespiratory Distress Syndrome, Adult|Respiratory Insufficiency|Shock, Cardiogenichttps://ClinicalTrials.gov/show/NCT00157144
183094183094Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn PatientsCompletedNo Results AvailableDeep Partial or Full Thickness WoundsDrug: Fibrin Sealant, Tisseel 4IU/ml VH SDhttps://ClinicalTrials.gov/show/NCT00157131
183095183095Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C DeficiencyCompletedNo Results AvailableProtein C DeficiencyDrug: Protein C Concentrate (Human) Vapor Heatedhttps://ClinicalTrials.gov/show/NCT00157118
183096183096Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing SurgeryCompletedNo Results AvailableHemophilia ADrug: Antihemophilic factor, recombinant, manufactured protein-freehttps://ClinicalTrials.gov/show/NCT00157105
183097183097Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin DeficiencyCompletedNo Results AvailableAlpha 1-Antitrypsin DeficiencyDrug: Aerosolized, Recombinant Alpha 1-Antitrypsinhttps://ClinicalTrials.gov/show/NCT00157092
183098183098Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency DisordersCompletedNo Results AvailablePrimary Immunodeficiency Disorders|Immune Thrombocytopenic Purpura (ITP)|Kawasaki SyndromeBiological: Immune Globulin Intravenous (Human), 10%https://ClinicalTrials.gov/show/NCT00157079
183099183099Effects of Vitamin D Supplementation on Antimycobacterial ImmunityCompletedNo Results AvailableTuberculosisDrug: Ergocalciferolhttps://ClinicalTrials.gov/show/NCT00157066
183100183100Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901CompletedNo Results AvailableHemophilia ADrug: Antihemophilic factor, recombinant, manufactured protein-freehttps://ClinicalTrials.gov/show/NCT00157053
183101183101Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia ACompletedNo Results AvailableHemophilia ADrug: Antihemophilic factor, recombinant, manufactured protein-freehttps://ClinicalTrials.gov/show/NCT00157040
183102183102RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)WithdrawnNo Results AvailableHIV InfectionsProcedure: Extracorporeal photochemotherapy with UVADEXhttps://ClinicalTrials.gov/show/NCT00157027
183103183103Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic RegimensCompletedHas ResultsHeart Transplantation|Heart DiseasesDrug: Tacrolimus|Drug: Cyclosporine|Drug: Mycophenolate mofetil|Drug: Methylprednisolone|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00157014
183104183104Feasibility Study of Photopheresis Post AngioplastyTerminatedNo Results AvailableStable Angina Pectoris|Unstable Angina Pectoris|Silent IschemiaProcedure: Photopheresis Post Angioplastyhttps://ClinicalTrials.gov/show/NCT00157001
183105183105The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness BurnsCompletedNo Results AvailableBurnsDrug: cerium nitrate-silver sulfadiazine (cerium-flamazine)https://ClinicalTrials.gov/show/NCT00156988
183106183106Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver MetastasesActive, not recruitingNo Results AvailableColorectal Neoplasms|Liver MetastasesDrug: Capecitabine|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00156975
183107183107Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)TerminatedNo Results AvailableChronic Kidney DiseaseDrug: Epoetin alfa DT|Drug: Epoetin alfa RBhttps://ClinicalTrials.gov/show/NCT00156962
183108183108EPO Deep Tank in Dialysis SubjectsCompletedNo Results AvailableChronic Kidney DiseaseDrug: Epoetin alfa DThttps://ClinicalTrials.gov/show/NCT00156949
183109183109ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])TerminatedHas ResultsAlcoholism|Opiate DependenceDrug: Medisorb naltrexone 380 mg|Drug: Oral naltrexone to Medisorb naltrexone 380 mghttps://ClinicalTrials.gov/show/NCT00156936
183110183110ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent AdultsCompletedHas ResultsAlcoholismDrug: Medisorb naltrexone 380 mg|Drug: Medisorb naltrexone 190 mghttps://ClinicalTrials.gov/show/NCT00156923
183111183111A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent HeadachesCompletedHas ResultsMigraine DisordersBiological: Botulinum Toxin Type A|Other: Placebo (saline)https://ClinicalTrials.gov/show/NCT00156910
183112183112Efficacy and Safety of ATL-962 in Obese DiabeticsCompletedNo Results AvailableNon-Insulin-Dependent Diabetes Mellitus|ObesityDrug: ATL-962|Drug: Orlistathttps://ClinicalTrials.gov/show/NCT00156897
183113183113A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate CancerCompletedNo Results AvailableHormone Refractory Prostate Cancer|Bone MetastasesDrug: strontium-89|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00156884
183114183114Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)CompletedNo Results AvailableFatigueBehavioral: exercisehttps://ClinicalTrials.gov/show/NCT00156871
183115183115Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic StudyRecruitingNo Results AvailableHematologic MalignancyDrug: intravenous busulfanhttps://ClinicalTrials.gov/show/NCT00156858
183116183116Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary AngiographyCompletedNo Results AvailableCoronary Artery DiseaseProcedure: AI-700 contrast-enhanced echocardiographyhttps://ClinicalTrials.gov/show/NCT00156845
183117183117The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial (The LOCCS Trial)CompletedNo Results AvailableAsthmaDrug: fluticasone|Drug: montelukast|Drug: fluticasone/salmeterol combinationhttps://ClinicalTrials.gov/show/NCT00156819
183118183118Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.CompletedNo Results Available#NAME?Procedure: Aloe barbadensis topical application in a moisturizing cream vehicle.https://ClinicalTrials.gov/show/NCT00156806
183119183119Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT ImagingCompletedNo Results AvailableCoronary Artery DiseaseProcedure: AI-700 contrast-enhanced echocardiographyhttps://ClinicalTrials.gov/show/NCT00156793
183120183120Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHFCompletedNo Results AvailableCongestive Heart Failure|Chronic Obstructive Pulmonary DiseaseDrug: AI-700https://ClinicalTrials.gov/show/NCT00156780

* Görseller ve İçerik tekif hakkına sahip olabilir